AI-Assisted Colorectal Cancer Screening: An Innovative Practice at the American Hospital of Paris

The American Hospital of Paris’s Gastroenterology and Hepatology Unit is proud to bring its patients AI-assisted colonoscopy, a technology that significantly improves the detection of colorectal cancers. Within just a few weeks, the generosity of our donors made it possible to fully fund the acquisition of CAD EYE, a software module that ensures an even more reliable, accurate and rapid diagnosis. Thank you for your generosity!colonoscopy.
Help us fund this innovative new technology to improve colorectal cancer screening and care.
Financed
Project entirely funded through donations / Total cost: €47,900
Image couv LAM79

AI-Assisted Endoscopy, a Powerful New Technology

The powerful CAD EYE software, developed by Fujifilm, was designed to improve the detection of polyps of all sizes and shapes and enable their characterization during colonoscopy. To do so, it comparatively analyzes a massive volume of images from clinical archives. Whenever a suspicious polyp is detected, a sound signal plays and a detection box shows the area where the polyp was found. The tool can also detect multiple polyps simultaneously and objectively characterize them as adenomatous or benign.

 

Significant Benefits

  • Improved colorectal cancer screening enabling faster treatment
  • Increased number of adenomas successfully detected, and decreased colorectal cancer risk
  • Fewer polypectomies and a lower risk of complications (such as bleeding or infection) associated with the resection of benign polyps

    “Today, thanks to support from donors, we can expand the use of AI-assisted endoscopy, an innovative technique enabling extremely accurate diagnoses. This technology increases the number of adenomas detected and decreases the number of polypectomies, thereby lowering the risk of complications, all of which are important benefits for the patient. And so on behalf of our entire team, I would like to thank all those who chose to support our project to improve colorectal cancer screening.”

Dr. Olivier Spatzierer, Chief of the Gastroenterology and Hepatology Unit

Dr Olivier Spatzierer